Peptides in Vascular Dementia
Tomorrows Episode...
Can peptide biology protect the brain from vascular damage? John follows a question that started with Vesugen into the biology of vascular cognitive impairment—endothelial dysfunction, hypoperfusion, blood-brain-barrier injury, mitochondrial stress, inflammation and neuronal damage. The episode maps Cerebrolysin, SS-31/elamipretide, ARA-290/cibinetide, Semax, Vesugen and GLP-1 receptor agonists onto different points in that cascade, then asks the question that matters: what does the human evidence actually support? Cerebrolysin provides the biggest surprise, with randomized vascular-dementia trials—but still low-certainty evidence. Educational only; not medical advice.
1
0 comments
John Garrett
5
Peptides in Vascular Dementia
powered by
Peptides Explained
skool.com/peptides-explained-1547
Peptides Explained: science-first peptide education without hype, bro-science, or medical advice. Learn mechanisms, research, risks, and trends.
Build your own community
Bring people together around your passion and get paid.
Powered by